130
Participants
Start Date
July 11, 2023
Primary Completion Date
May 10, 2026
Study Completion Date
May 10, 2026
Tapering and/or discontinuation of treatment based on AI-guidance
After synovial tissue biopsy, pharmacological treatment (cDMARDs or bDMARDs) are tapered first and then bDMARDs and/or cDMARDs are discontinued based on AI-guidance
No tapering and/or discontinuation of treatment based on AI-guidance
Ongoing therapeutic are not changed (tapered or discontinued) after synovial biopsy performance based on AI-guidance
Tapering and/or discontinuation of treatment based on standard of care
After synovial tissue biopsy, pharmacological treatment (cDMARDs or bDMARDs) are tapered first and then bDMARDs and/or cDMARDs are discontinued based on standard of care
No tapering and/or discontinuation of treatment based on standard of care
Ongoing therapeutic are not changed (tapered or discontinued) after synovial biopsy performance based on standard of care
RECRUITING
Division of Rheumatology, Rome
NOT_YET_RECRUITING
Hospital Clinic and Fundació Clinic per la Recerca Biomèdica, Barcelona
ACTIVE_NOT_RECRUITING
Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), Glasgow
ACTIVE_NOT_RECRUITING
Newcastle University, Newcastle upon Tyne
University of Glasgow
OTHER
Fundacion Clinic per a la Recerca Biomédica
OTHER
Newcastle University
OTHER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER